Troparil, also known as (-)-2β-Carbomethoxy-3β-phenyltropane (WIN 35,065-2), is a research chemical that belongs to the tropane class of psychostimulant compounds. It is a synthetic analog of cocaine and functions as a dopamine reuptake inhibitor, meaning that it increases the levels of dopamine in the brain by preventing its reuptake into presynaptic neurons. Troparil is a white crystalline powder that is typically administered orally, intranasally, or intravenously.
Troparil produces a range of physiological and psychological effects that are similar to those of cocaine, but are generally less intense and shorter in duration. The drug increases alertness, concentration, and energy levels, while also inducing feelings of euphoria and well-being. It can also cause changes in heart rate, blood pressure, body temperature, and pupil size. Troparil’s effects are highly dose-dependent, and the drug can be habit-forming with regular use.
As a research chemical, Troparil is primarily used to study the effects of dopamine reuptake inhibition on brain function and behavior. It has been shown to be effective in animal models of drug addiction, and may have potential as a medication for treating cocaine addiction and other substance use disorders. Additionally, Troparil has been investigated for its potential as a performance-enhancing drug, due to its ability to increase physical endurance and cognitive function.
Troparil is a highly potent psychoactive substance that can pose significant risks to health and safety if used improperly. It has not been approved for human consumption or medical use, and is not intended for recreational use. The drug can cause a range of adverse effects, including cardiovascular problems, seizures, psychosis, and addiction. Individuals with preexisting medical conditions or psychiatric disorders should avoid using Troparil, as it can exacerbate these conditions. It is important to use proper safety equipment and follow appropriate laboratory procedures when handling and studying this compound.